Nalu Medical, Inc. Announces $65 Million Equity Financing To Advance Treatment For Chronic Neuropathic Pain
Nalu Medical, Inc. Announces $65 Million Equity Financing To Advance Treatment For Chronic Neuropathic Pain
01/03/24, 4:06 PM
Location
carlsbadMoney raised
$65 million
Industry
medical device
medical
biotechnology
health care
Investors
Aperture Venture Partners, Pura Vida, Advent Life Sciences, Longitude Capital, Decheng Capital, Endeavor Vision, Mvm Partners, Gilde Healthcare, Novo Holdings
Nalu Medical Inc. (Nalu), a private company focused on innovative, minimally invasive, and non-opioid solutions for chronic neuropathic pain, announced today the closing of a $65 million equity financing. The round was led by a new investor, Novo Holdings (Novo). Also participating in the round were all of the Nalu existing significant investors: Gilde Healthcare, MVM Partners, Endeavor Vision, Decheng Capital, Longitude Capital, Advent Life Sciences, Pura Vida, and Aperture Venture Partners
Company Info
Location
carlsbad, california, united states
Additional Info
Nalu is a Carlsbad, California-based medical technology company focused on developing and commercializing innovative and minimally invasive solutions for patients with chronic neuropathic pain. The Nalu Neurostimulation System delivers gentle electrical pulses to the nervous system to modulate pain signals before they get to the brain. The Nalu System was designed to address major unmet needs in the treatment of chronic neuropathic pain and provide a differentiated value proposition for patients and physicians.